By enhancing mitochondrial health, SS-31 may support better endurance, strength, and post-workout recovery of muscles
According to the American Association of Clinical Endocrinologists and American College of Endocrinology (AACE/ACE) Obesity Clinical Practice Guidelines, weight loss medications should be offered as chronic treatment along with lifestyle modifications to patients with obesity when the potential benefits outweigh the risks
Continue escalating tirzepatide as needed per standard protocols
B12 shots can last in their benefits for about one to two weeks
Evidence suggests that the effect may be greatest for semaglutide once weekly, followed by dulaglutide and liraglutide, closely followed by exenatide once weekly, and then exenatide twice daily and lixisenatide
This is another reason adequate B12 support during treatment matters